
Opinion|Videos|March 26, 2024
Treatment Sequencing and Combination Therapies for MM
Carol Ann Huff, MD discusses how the approval of additional bispecific antibodies for multiple myeloma might change the treatment selection process, highlighting considerations for sequencing of agents and combination therapy.
Advertisement
Episodes in this series

Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
MONALEESA Data Reveal Robust Long-Term Disease Control With Ribociclib
2
Advancing Treatment After CDK4/6 Inhibitor Progression in HR+/HER2– Breast Cancer
3
Pharmacists, Don’t Fear AI: ASHP Framework Shows How to Embrace AI
4
A Supplemental Blood Test to Bridge Gaps in Breast Cancer Screening Access
5





















































































































































































































